How AI and Wearables Are Revolutionizing Women's Health Care

Women's health technology is rapidly evolving from simple period trackers into sophisticated AI-powered platforms that can predict health outcomes, monitor hormones continuously, and provide personalized care across a woman's entire lifespan. The FemTech market is expected to reach $130.8 billion by 2034, driven by innovations that address decades of under-researched women's health conditions.

What Makes Modern Women's Health Tech Different?

Today's women's health apps are moving far beyond symptom tracking. Artificial intelligence is transforming the sector from passive monitoring to predictive, proactive care using machine learning models that draw data from wearables to anticipate health outcomes before symptoms appear.

Natural Cycles, the first birth control app to receive Food and Drug Administration (FDA) approval, processes more than 20 million temperature readings daily and is reportedly 98% effective when used correctly. Meanwhile, Flo Health uses AI models to analyze more than 70 symptoms and life events, while Clue's algorithms help users predict fertility windows, premenstrual syndrome (PMS), and cycle irregularities.

How Are Wearables Changing Pregnancy and Hormone Monitoring?

Predictive analytics are reshaping pregnancy care in remarkable ways. A 2024 study using the Oura Ring to track 120 pregnancies found that continuous monitoring of heart rate, heart-rate variability, and body temperature could reveal patterns linked to early pregnancy loss and trimester-specific complications.

The hormone tracking revolution is particularly exciting. New technologies are moving beyond single-point tests to capture hormone dynamics in real time. Several innovative companies are leading this charge:

• Saliva-Based Tracking: Inne, a German-UK company that raised €18.8 million, became the first saliva-based contraception certified in the UK and Europe in June 2025, predicting and confirming ovulation through at-home saliva tests
• Real-Time Hormone Insights: Eli Health from Canada secured $12 million in June 2025 to develop a saliva-testing stick that provides real-time insights into cortisol levels, with progesterone, testosterone, and estradiol in development
• Multi-Hormone Testing: Mira, a US-based company, offers FDA and CE registered numeric estrogen and luteinizing hormone tests with 99% accuracy using the same fluorescence-based technology found in labs

"Abu Dhabi's focus on innovation, healthcare and entrepreneurship has made it possible to start and grow businesses that have a big impact," said Majd Abu Zant, co-founder of Ovasave, highlighting how emerging markets are becoming crucial for FemTech growth.

Why Does Hormone Tracking Matter Beyond Fertility?

While research in women's health still focuses heavily on fertility and pregnancy, female hormones profoundly influence cardiovascular, neurological, cognitive, immune, and oral health across the entire lifespan. Only 12% of all scientific journals on gynecology and obstetrics are dedicated to women's health issues unrelated to their reproductive role, and a mere 4% deal with the health of women before and after their reproductive years.

The broader health impacts are significant. Higher testosterone-to-estradiol ratios are associated with elevated cardiovascular disease risk in postmenopausal women. Among women with attention deficit hyperactivity disorder (ADHD), 98% reported cognitive and mood changes corresponding to hormonal fluctuations, with symptoms worsening during phases when estrogen is low.

Remote monitoring technologies that track blood pressure, glucose levels, and stress biomarkers during pregnancy and the postnatal period are improving maternal outcomes by helping identify conditions such as gestational diabetes at earlier stages. Innovations such as AI-powered ultrasound analysis for early suspicion of endometriosis and sensor-enabled pelvic floor trainers are bringing scientific rigor to conditions that were once dismissed as "normal."

By 2030, more than one billion women will be in perimenopause or menopause, making this area particularly ripe for technological innovation. What began as simple symptom-logging apps has evolved into full-fledged platforms that offer telehealth, AI-based flare-up prediction, and non-hormonal therapies.

The future of women's health technology lies in unified platforms that integrate wearable data, laboratory results, and clinical records into a single long-term health timeline. Such systems could significantly improve care coordination and enable faster, more informed decision-making, moving beyond fragmented tracking across multiple devices and apps.